121 related articles for article (PubMed ID: 12467613)
1. Homologues and isomers of noladin ether, a putative novel endocannabinoid: interaction with rat cannabinoid CB(1) receptors.
Appendino G; Ligresti A; Minassi A; Daddario N; Bisogno T; Di Marzo V
Bioorg Med Chem Lett; 2003 Jan; 13(1):43-6. PubMed ID: 12467613
[TBL] [Abstract][Full Text] [Related]
2. 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor.
Hanus L; Abu-Lafi S; Fride E; Breuer A; Vogel Z; Shalev DE; Kustanovich I; Mechoulam R
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3662-5. PubMed ID: 11259648
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, in vitro evaluation, and intraocular pressure effects of water-soluble prodrugs of endocannabinoid noladin ether.
Juntunen J; Vepsäläinen J; Niemi R; Laine K; Järvinen T
J Med Chem; 2003 Nov; 46(23):5083-6. PubMed ID: 14584958
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid.
Laine K; Järvinen K; Mechoulam R; Breuer A; Järvinen T
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3216-22. PubMed ID: 12356827
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoid structure-activity relationships for interaction at the cannabinoid receptors.
Reggio PH
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):143-60. PubMed ID: 12052032
[TBL] [Abstract][Full Text] [Related]
6. Resorcinol-sn-glycerol derivatives: novel 2-arachidonoylglycerol mimetics endowed with high affinity and selectivity for cannabinoid type 1 receptor.
Brizzi A; Cascio MG; Frosini M; Ligresti A; Aiello F; Biotti I; Brizzi V; Pertwee RG; Corelli F; Di Marzo V
J Med Chem; 2011 Dec; 54(24):8278-88. PubMed ID: 22044209
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the synthesis of endocannabinoid related ligands.
Razdan RK; Mahadevan A
Chem Phys Lipids; 2002 Dec; 121(1-2):21-33. PubMed ID: 12505687
[TBL] [Abstract][Full Text] [Related]
8. Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes.
Savinainen JR; Järvinen T; Laine K; Laitinen JT
Br J Pharmacol; 2001 Oct; 134(3):664-72. PubMed ID: 11588122
[TBL] [Abstract][Full Text] [Related]
9. Endocannabinoids and related fatty acid derivatives in pain modulation.
Walker JM; Krey JF; Chu CJ; Huang SM
Chem Phys Lipids; 2002 Dec; 121(1-2):159-72. PubMed ID: 12505698
[TBL] [Abstract][Full Text] [Related]
10. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of accumbens shell cannabinoid CB(1) receptors by noladin ether, a putative endocannabinoid, modulates food intake and dietary selection in rats.
Deshmukh RR; Sharma PL
Pharmacol Res; 2012 Sep; 66(3):276-82. PubMed ID: 22728691
[TBL] [Abstract][Full Text] [Related]
12. Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues.
Fezza F; Bisogno T; Minassi A; Appendino G; Mechoulam R; Di Marzo V
FEBS Lett; 2002 Feb; 513(2-3):294-8. PubMed ID: 11904167
[TBL] [Abstract][Full Text] [Related]
13. Development of endocannabinoid-based chemical probes for the study of cannabinoid receptors.
Martín-Couce L; Martín-Fontecha M; Capolicchio S; López-Rodríguez ML; Ortega-Gutiérrez S
J Med Chem; 2011 Jul; 54(14):5265-9. PubMed ID: 21675776
[TBL] [Abstract][Full Text] [Related]
14. The endocannabinoid system: function in survival of the embryo, the newborn and the neuron.
Fride E; Shohami E
Neuroreport; 2002 Oct; 13(15):1833-41. PubMed ID: 12395075
[TBL] [Abstract][Full Text] [Related]
15. Noladin ether, a putative endocannabinoid, enhances motivation to eat after acute systemic administration in rats.
Jones EK; Kirkham TC
Br J Pharmacol; 2012 Jul; 166(6):1815-21. PubMed ID: 22309979
[TBL] [Abstract][Full Text] [Related]
16. The cannabinoid receptors.
Howlett AC
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():619-31. PubMed ID: 12432948
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
[TBL] [Abstract][Full Text] [Related]
18. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.
Di Marzo V; Breivogel CS; Tao Q; Bridgen DT; Razdan RK; Zimmer AM; Zimmer A; Martin BR
J Neurochem; 2000 Dec; 75(6):2434-44. PubMed ID: 11080195
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoids in the central nervous system--an overview.
Fride E
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):221-33. PubMed ID: 12052038
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism.
Ortar G; Bisogno T; Ligresti A; Morera E; Nalli M; Di Marzo V
J Med Chem; 2008 Nov; 51(21):6970-9. PubMed ID: 18831576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
